GLP-1
Treatment Review
← Peptide library

The evidence reference

Bremelanotide

Vyleesi

Approved product

Sources checked 2026-10-27

Reading this profile

If a report uses questionnaires, examine what the questions are intended to capture before interpreting a score. Look for the scale description, the timing of responses, and the explanation of what a change represents. Distinguish separate outcomes even when a headline folds them into one broad idea of improvement. If the report sets a threshold for a meaningful change, check whether that threshold was specified in advance and how it is justified. This keeps the reader focused on the experience actually measured and the reasoning used to turn a score into a conclusion.

Formulation and route

Subcutaneous injection.

Mechanism

Melanocortin-receptor agonist.

Research evidence

Randomized trials.

Limits of the evidence

Exclude medical, relationship and drug causes; not performance enhancement.

Safety context

Uncontrolled hypertension or known cardiovascular disease: contraindicated.

Questions to take further

  1. What experience is each questionnaire or score intended to measure?
  2. Does the summary combine distinct outcomes into a single claim of improvement?
  3. How was the threshold for a meaningful change chosen and explained?

Original sources

  1. VYLEESINLM · Checked 2026-10-27
  2. Kingsberg trialsPubMed · Checked 2026-10-27

Continue your research

An educational reference from the Comparison Desk. AI-assisted; not reviewed by a licensed clinician. This library does not provide prescriptions or instructions for self-treatment.